Hap1 and GABA: Thinking about food intake  by Woods, Stephen C. & Seeley, Randy J.
covalent modifications (e.g., phosphory-
lation or methylation), and the composite
of these modifications rather than any
one change alone is thought to provide
a signature code for transcriptional acti-
vation or repression. In S. cerevisiae, for
example, GCN5 and SNF1, the yeast ho-
molog of AMPK, coordinately regulate
gene expression by carrying out the se-
quential phosphorylation and acetylation
of histone H3 in response to glucose
depletion (Lo et al., 2001). In view of its
ability to block gluconeogenesis in mam-
mals, AMPK may similarly phosphorylate
and inhibit PGC-1a by enhancing subse-
quent acetylation via GCN5 when cellular
levels of ATP are low.
Future studies should reveal as well
the extent to which the observed antago-
nism between GCN5 and SIRT1 on PGC-
1a activity extends to other activators like
FOXO1 that also regulate gluconeogene-
sis. Should this yin-yang relationship be-
tween GCN5 and SIRT1 hold more gen-
erally, then compounds that enhance
GCN5 HAT activity might be expected
to provide therapeutic benefit for the
treatment of hyperglycemia and insulin
resistance in type 2 diabetic patients.
Whatever the results, the current study
provides much food for thought about
the regulatory mechanisms employed to
maintain energy balance during fasting.
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Figure 1. SIRT1 integrates nutrient and hormonal cues to modulate induction of the gluconeogenic program
During fasting, pancreatic glucagon stimulates expression of PGC-1a in the liver. Elevations in gluconeogenic
precursors like pyruvate promote accumulation of SIRT1 protein, which in turn triggers induction of gluconeo-
genic genes by catalyzing the NAD+-dependent deacetylation of PGC-1a.
P R E V I E W SHap1 and GABA: Thinking about food intake
GABA stimulation of hypothalamic GABAA receptors increases food intake and body weight. Huntingtin-associated protein-
1 (Hap1), is highly expressed in the hypothalamus and increases activity at GABAA receptors; mice lacking Hap1 are
hypophagic. A recent paper (Sheng et al., 2006) further explores the role of Hap1 in the control of food intake.Several major classes of molecules con-
trol synaptic signaling between brain cells.
One of these classes, neuropeptides, can
be considered to act at a system-wide
level, that is, causing diverse responses at
different sites in the brain that collectively
integrate toreachacommonendpoint.For
example, melanocortins such as a-mela-
nocyte-stimulating hormone (aMSH) act
in the hypothalamus, the brainstem,
and elsewhere to reduce energy intake388and increase energy expenditure (Cone,
2005); corticotropin-releasing hormone
(CRH) acts throughout the brain co-
ordinating endocrine and behavioral re-
sponses to real or perceived stressors
(Hillhouse and Grammatopoulos, 2006).
A second class of compounds, biogenic
amines, can be considered as setting a
background or tone that influences multi-
ple systems simultaneously. For example,
noradrenergic axons originating in thebrainstem radiate throughout the brain,
setting the level of arousal (Aston-Jones
and Cohen, 2005). At a different level, a
third class, amino acid transmitters such
as glutamate and g-aminobutyric acid
(GABA), do much of the synaptic work of
the brain, integrating inputs from multiple
sources to provide the appropriate level
of stimulation or inhibition to circuits con-
trolling responses. Indeed, glutamatergic
and GABAergic receptors collectivelyCELL METABOLISM : JUNE 2006
P R E V I E W SFigure 1. Postulated model for the influence of Huntingtin-associated protein-1 on food intake in the hypo-
thalamus
GABA stimulates GABAA receptors, triggering events that lead to continued eating. Hap1 enhances this
process, and Huntingtin-associated protein-1 (Hap1) levels are in turn increased by fasting and decreased
by feeding and insulin.account for a disproportionately large
number of the total receptors within the
brain (Van den Pol, 2003). Adding to the
overall complexity is the fact that individual
neurons often utilize several different neu-
rotransmitters, potentially from several
separate classes, thereby producing
multiple types of signals. Individual neu-
rons can also receive multiple types of
input from the periphery, such as hor-
mones, nutrients, and the major sensory
systems.
Understanding the interactions be-
tween these processes in the context of
individual responses or actions can be
daunting. A case in point is the control
of energy homeostasis, for which a rich
literature documents the role of individual
neuropeptides, biogenic amines, amino
acids, hormones, and nutrients that influ-
ence food intake (Schwartz et al., 2000;
Seeley and Woods, 2003). At the same
time, information on interactions of these
different categories of signals as they
modify food intake is relatively scarce. A
recent report by Sheng and colleagues
in Nature Medicine (Sheng et al., 2006)
addresses this question. This group has
found that Huntingtin-associated pro-
tein-1 (Hap1), an interacting partner for
the Huntington disease protein which
participates in intracellular trafficking, is
highly expressed in the hypothalamus
and that mice lacking Hap1 eat less than
controls and die at a very young age.
Furthermore, Hap1 increases activity atCELL METABOLISM : JUNE 2006GABAA receptors (Kittler et al., 2004),
and increased GABA activity locally
within the hypothalamus has been shown
to increase food intake (Van den Pol,
2003). Sheng et al. (Sheng et al., 2006)
found that fasting upregulates hypotha-
lamic HAP1 and that carbohydrate feed-
ing reduces HAP1 expression.
Insulin is recognized to provide an im-
portant adiposity signal to the brain; insu-
lin levels are decreased with fasting and
increased on a carbohydrate diet, and hy-
pothalamic insulin administration re-
duces food intake (Schwartz et al.,
2000; Seeley and Woods, 2003; Woods,
2005). Sheng et al. therefore adminis-
tered insulin into the 3rd cerebral ventricle
or onto hypothalamic slices of mice and
observed decreased levels of Hap1
mRNA and protein; furthermore, they
provide evidence that the decrease is at-
tributable to increased degradation of
Hap1 by the ubiquitin-proteasome path-
way. The effect was specific in that nei-
ther glucose nor leptin, other compounds
that decrease food intake, had any effect.
When they subsequently administered
Hap1-specific siRNA into the hypotha-
lamic paraventricular nucleus (PVN) or
dorsomedial hypothalamus (DMH), areas
that integrate catabolic signals, animals
ate less and lost body weight, whereas
cortical administration was without
effect. The animals also had reduced
GABAA functioning in the hypothalamus.
Based on these observations, Shenget al. concluded that insulin decreases
food intake by decreasing Hap1 levels
within the hypothalamus and conse-
quently reducing activity at GABAA
receptors, implying that Hap1 has a
specific, critical role in the normal control
of energy homeostasis (Figure 1). This
hypothesis would predict that insulin
administration to mice with reduced
Hap1 would have little effect, but the re-
sults of this difficult experiment remain
unknown.
Caution is called for when interpreting
results based on reductions of food in-
take since incapacitation, illness, or gen-
eral behavioral depression all cause the
same endpoint as increased caloric sig-
naling (Woods et al., 1998). These issues
are particularly relevant for signaling sys-
tems such as GABA that are relatively
ubiquitous in neuronal circuits. In particu-
lar, Hap1-deficient animals die at a very
young age (Chan et al., 2002). To their
credit, Sheng et al. (Sheng et al., 2006)
attempted to increase Hap1 activity in
the hypothalamus by injection of hap1A-
adenovirus vectors to elicit a behavioral
effect opposite to that seen with reduc-
tion of Hap1. The Hap1A isoform is
known to stabilize membrane receptors.
The authors observed a modest, tran-
sient increase of food intake, but without
clear evidence of increased Hap1A, they
conclude that the system is best investi-
gated by suppressing rather than stimu-
lating Hap1. Such an outcome highlights
the difficulty of drawing firm conclusions
about the specific role of a protein that
likely exerts broad effects via interactions
with the GABA system. As the authors
point out, more than 50% of the synap-
ses in the hypothalamus use GABA
(Decavel and Van den Pol, 1990), and
Hap1 seems to be present in most if not
all hypothalamic areas. Reducing Hap1
is therefore likely to cause dysregulation
of multiple hypothalamic systems simul-
taneously. Additional information about
the nature of the transient increases in
food intake, and the effects of Hap1
manipulations on total body fat and cir-
culating insulin levels, will provide further
evidence to test the authors’ hypothesis.
Also critically informative will be direct
electrophysiological measurement of
the effect of Hap1 on GABA transmission
in specific populations of hypothalamic
neurons.
In sum, while provocative, the data of
Sheng et al. (Sheng et al., 2006) prompt
an appreciation of the perils of studying389
P R E V I E W Sthe circuitry that regulates food intake
and body weight, particularly in the
context of such ubiquitous systems.
Future work in which either loss- or
gain-of-function manipulations can be
directed to specific cell populations,
rather than anatomical locations, will
provide further key insights to the
specific role of Hap1 in regulating energy
balance.
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In addition to glucose, insulin secretion
from the endocrine pancreatic b cells is
stimulated by several neuropeptide hor-
mones and neurotransmitters, among
which acetylcholine, the muscarinic cho-
linergic receptor agonist, plays a promi-
nent role (Ahren, 2000; Gilon and Hen-
quin, 2001). Acetylcholine is released
during the preabsorptive and absorptive
phases of feeding from parasympathetic
(vagal) nerve endings present in the pan-
creatic islet (Ahren, 2000; Gilon and Hen-
quin, 2001). The insulinotropic effects of
acetylcholine result from two comple-
mentary mechanisms: One involves
stimulation of inositol phosphate produc-
tion and a rise in the cytoplasmic Ca2+
concentration, whereas the other in-
volves a protein kinase C-mediated in-
crease in the efficiency of Ca2+ on exocy-
tosis of the insulin-containing granules
(Figure 1; for review, see Gilon and Hen-
quin, 2001). The increase in efferent para-
sympathetic outflow results from the con-
vergence and integration of redundant
nutrient-related signals, which include
central and peripheral neural inputs, as
well as hormonal and nutritional signals
(Ahren, 2000). In short, the nervous sys-
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tem provides context for islet behavior,
optimizing the response of this endocrine
gland beyond what can be obtained with
glucose alone. The mechanisms underly-
ing this process are complex. In this is-
sue of Cell Metabolism, Gautam et al.
(2006) help clarify the role of the specific
M3 subtype of the muscarinic acetylcho-
line receptor family in glucose metabo-
lism in vivo.
At first glance, the involvement of ace-
tylcholine would seem to be a simple
matter to describe. However, despite de-
cades of study, the importance of acetyl-
choline in the maintenance of normal glu-
cose homeostasis remains unsettled.
Multiple muscarinic acetylcholine recep-
tor subtypes have been identified in the
b cell, making it difficult to assign specific
physiological functions to thehighlyabun-
dant M3 receptor. Additionally, peripheral
parasympathetic nerves release at least
five different neurotransmitters (all active
in the b cell and stimulating insulin secre-
tion), and most tissues or cell types ex-
press two or more muscarinic receptor
subtypes. Finally, increased parasympa-
thetic outflow also governs activities in
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b cell function
uscarinic acetylcholine receptors con-
egrating nervous stimuli with metabolic
important metabolic functions. This be-
came particularly obvious from studies
in mice with whole body deficiency of
the M3 muscarinic receptor, in which im-
pairments in insulin secretion were ob-
served in parallel with a paradoxical re-
duction in blood glucose levels. While
seemingly contradictory, the improve-
ment in glycemic control was most likely
due to a reduction in plasma glucagon
levels and reduced food intake (Yamada
et al., 2001; Duttaroy et al., 2004). Clearly,
to study the specific role played in vivo by
the b cell M3 receptor, one needs better
animal models (cell-specific knockouts)
or very precise pharmacological tools.
Gautam et al. (2006) now report the
generation of mutant mice selectively
lacking M3 muscarinic receptors in pan-
creatic b cells. These mice display im-
paired glucose tolerance and a dramatic
reduction in insulin secretion, thus dem-
onstrating that the activity of the b cell
M3 muscarinic receptors is essential
for maintaining normal glucose homeo-
stasis. It is well accepted that the acetyl-
choline-mediated preabsorptive phase
of insulin secretion (also called the ce-
phalic phase, not far removed from the
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